|
|
|
 |
| Location: Home -
Products - Reference Compounds&Impurities
|
LDN-193189
| Catalogue No. : |
C13804 |
| Product Name: |
LDN-193189 |
| Synonym: |
DM3189; LDN 193189 |
| Chemical Name: |
4-[6-[4-(1-Piperazinyl)phenyl]pyrazolo[1,5-a]pyrimidin-3-yl]quinoline |
| CAS No. : |
1062368-24-4 |
| Structure : |
|
| Molecular Formula: |
C25H22N6 |
| Molecular Weight: |
406.48 |
| Purity: |
98%+Min. |
| Usage: |
LDN-193189 is a selective BMP signaling inhibitor, inhibits the transcriptional activity of the BMP type I receptors ALK2 and ALK3 with IC50 of 5 nM and 30 nM in C2C12 cells, respectively, exhibits 200-fold selectivity for BMP versus TGF-β. |
|
| Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. As it is impossible for us to be informed about the patent situation in all countries, the liability for patent infringement is exclusively to be understood as buyer's risk. |
|
|
